Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study.
Parveen FathimaMark A JonesReena D'SouzaJames A TotterdellNada AndricPenelope A AbbottRichard NormanKirsten HowardWendy ChengAlisa E PedranaJoseph S DoyleJane DaviesThomas L SnellingPublished in: Trials (2024)
ANZCTR (anzctr.org.au), Identifier ACTRN12623000024640, Registered 11 January 2023 ( https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=384923&isReview=true ).
Keyphrases
- early stage
- clinical trial
- randomized controlled trial
- study protocol
- smoking cessation
- sensitive detection
- healthcare
- open label
- reduced graphene oxide
- squamous cell carcinoma
- cancer therapy
- replacement therapy
- sentinel lymph node
- combination therapy
- gold nanoparticles
- hepatitis c virus
- health insurance
- double blind
- antiretroviral therapy
- quantum dots